GARS1 and neoplasm: Five ARS-RNAi lines (LeuRS, MetRS, PheRS, TrpRS, and VarRS) showed no significant changes (Supplementary Figure S1A), whereas the AsnRS-, AlaRS-, AspRS-, and GlyRS-RNAi lines showed suppression of the overgrowth tumor phenotype (Figure 1B).